AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$710M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$539M |
| 3 |
CVS Health
CVS
|
+$365M |
| 4 |
Comcast
CMCSA
|
+$329M |
| 5 |
F5
FFIV
|
+$248M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$281M |
| 2 |
General Motors
GM
|
+$266M |
| 3 |
Conagra Brands
CAG
|
+$241M |
| 4 |
Cognizant
CTSH
|
+$218M |
| 5 |
Illinois Tool Works
ITW
|
+$199M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.5% |
| 2 | Healthcare | 12.97% |
| 3 | Technology | 12.75% |
| 4 | Consumer Discretionary | 10.91% |
| 5 | Industrials | 10.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
St. Joe Company
JOE
$3.54B
| $866K | ﹤0.01% |
44,977
-10,792
| -19% | -$200K |
|
2227
Interactive Brokers
IBKR
$39.2B
| $864K | ﹤0.01% |
159,500
-325,636
| -67% | -$1.8M |
|
2228
Century Aluminum
CENX
$4.43B
| $863K | ﹤0.01% |
65,340
+16,140
| +33% | +$188K |
|
|
ESPR
2229
DELISTED
Esperion Therapeutics
ESPR
| $861K | ﹤0.01% |
56,928
| – | – |
|
|
AFFX
2230
DELISTED
Affymetrix Inc
AFFX
| $861K | ﹤0.01% |
120,690
+290
| +0.2% | +$2.34K |
|
2231
Lexicon Pharmaceuticals
LXRX
$1.03B
| $859K | ﹤0.01% |
70,913
+6,686
| +10% | +$85.4K |
|
|
FURX
2232
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
| $858K | ﹤0.01% |
9,860
+4,523
| +85% | +$349K |
|
|
SRDX
2233
DELISTED
Surmodics
SRDX
| $849K | ﹤0.01% |
37,554
-700
| -2% | -$17.1K |
|
2234
Forrester Research
FORR
$223M
| $848K | ﹤0.01% |
23,666
-2,003
| -8% | -$74.6K |
|
|
VG
2235
DELISTED
Vonage Holdings Corporation
VG
| $845K | ﹤0.01% |
197,824
-13,959
| -7% | -$59.5K |
|
|
AMRN
2236
Amarin Corp
AMRN
$299M
| $842K | ﹤0.01% |
23,271
+23,171
| +23,171% | +$861K |
|
2237
Universal Electronics
UEIC
$57.8M
| $842K | ﹤0.01% |
21,944
| – | – |
|
|
CMLS
2238
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $842K | ﹤0.01% |
15,225
| – | – |
|
|
LDR
2239
DELISTED
Landauer Inc
LDR
| $841K | ﹤0.01% |
18,550
-3
| -0% | -$147 |
|
|
CFNL
2240
DELISTED
Cardinal Financial Corp
CFNL
| $841K | ﹤0.01% |
47,179
| – | – |
|
2241
M/I Homes
MHO
$3.74B
| $839K | ﹤0.01% |
37,400
-19
| -0.1% | -$454 |
|
|
SPPI
2242
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $839K | ﹤0.01% |
107,048
-38
| -0% | -$322 |
|
2243
Lloyds Banking Group
LYG
$89.5B
| $836K | ﹤0.01% |
164,310
-2,832
| -2% | -$15.4K |
|
2244
Vera Bradley
VRA
$97M
| $836K | ﹤0.01% |
30,976
+900
| +3% | +$23K |
|
|
WSTC
2245
DELISTED
West Corporation
WSTC
| $833K | ﹤0.01% |
34,830
-1,400
| -4% | -$34.3K |
|
2246
Southside Bancshares
SBSI
$967M
| $831K | ﹤0.01% |
31,423
-942
| -3% | -$22.7K |
|
2247
Extreme Networks
EXTR
$3.94B
| $830K | ﹤0.01% |
143,043
| – | – |
|
2248
TherapeuticsMD
TXMD
$23.5M
| $823K | ﹤0.01% |
2,608
+2,574
| +7,571% | +$820K |
|
|
EBIX
2249
DELISTED
Ebix Inc
EBIX
| $821K | ﹤0.01% |
48,090
+42,690
| +791% | +$658K |
|
2250
Prothena Corp
PRTA
$425M
| $819K | ﹤0.01% |
21,377
+21,300
| +27,662% | +$687K |
|
Similar funds
AllianceBernstein's Q1 2014 Portfolio in Review
As of Q1 2014, AllianceBernstein held 3,797 positions worth $116B, up 3.5% from $112B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AllianceBernstein's Q1 2014 filing shows 299 new, 987 increased, 1,835 reduced and 105 closed positions. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 281,840 shares worth $16.7M. The largest sale was Marathon Petroleum, an estimated $281M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.
- AllianceBernstein's largest Q1 2014 buy was GW Pharmaceuticals Plc American Depositary Shares: 281,840 shares worth $16.7M.
- AllianceBernstein added most to Verizon in Q1 2014, an estimated $710M increase.
- AllianceBernstein's biggest Q1 2014 reduction was Marathon Petroleum, cutting an estimated $281M.
- AllianceBernstein fully exited LIFE TECHNOLOGIES CORP COM STK (DE) in Q1 2014, selling an estimated $24.5M.
- AllianceBernstein's ten largest holdings make up 13% of its $116B portfolio in Q1 2014.
- AllianceBernstein opened 299 new positions and closed 105 in Q1 2014.
- AllianceBernstein's portfolio value rose 3.5% quarter-over-quarter to $116B.
Based on AllianceBernstein's 13F filing for Q1 2014, filed 13 May 2014.